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Cancer is one of the most dreaded diagnoses from a physiological, psychological, social
and spiritual standpoint, and is the second leading cause of death in the United States (Zhou,
Stoitzfus, & Swan, 2009). Currently, breast cancer is the leading cause of cancer morbidity and
mortality among women and accounts for thirty one percent of all female cancers.
Approximately 1,150,000 cases and 410,000 deaths occur globally each year from breast cancer
(Mohr, Garland, Gorham, Grant, and Garland, 2008). In addition, it is also well documented that
breast cancer survival rates vary considerably from one geographic area to another (Sariego,
2009). Breast cancer death rates tend to be higher in areas with low winter sunlight levels and
lower in sunny areas (Garland et al, 2006). This raises the question, is there an inverse
relationship between the incidence of breast cancer and vitamin D supplementation?
Vitamin D deficiency is an epidemic health problem. In the United States, twenty five to
fifty eight percent of adolescents and adults are vitamin D deficient. The prevalence of vitamin D
deficiency among people diagnosed with cancer is much higher, approaching ninety percent
(Zhou, Stoitzfus, &Swan, 2009). The high risk of vitamin D deficiency, combined with the
discovery of increased risks of certain types of cancer in those who are deficient, suggests
vitamin D deficiency may account for several thousand premature deaths from different types of
cancer annually (Garland et al, 2006).
Populations living farther from the equator have higher overall cancer death rates
compared to those living closer to the equator, thus suggesting an increase in sun exposure, and
an increase in vitamin D, have lead to decreased cancer-associated mortality (Vijayakumar et al.,
2006). The highest mortality rates occur in the northeast while the lowest mortality occurs in the
south. This suggests solar radiation may be protective against breast cancer, as it leads to vitamin
D synthesis (Vijayakumar et al., 2006).
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FIGURE 1 – Age adjusted breast cancer mortality rates by state, United States, 1940-1994.
Source: NCI Cancer Mortality Maps and Graphs (available at: http://cancercontrolplanet
.cancer.gov/atlas/index)
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Pathophysiolgy of Vitamin D and Breast Cancer

Breast cancer is a malignant tumor that starts from cells of the breast. A malignant tumor
is a group of cancer cells that may grow into (invade) surrounding tissues or spread (metastasize)
to distant areas of the body (American Cancer Society, 2009). Progression from normal tissue to
invasive cancer is thought to take place over five to twenty years and is influenced by hereditary
genetic factors as well as somatic genetic changes (Calvo, Petricoin,& Liotta, 2005). The disease
occurs almost entirely in women, but men may develop it as well (American Cancer Society,
2009).

Vitamin D is an essential vitamin the body needs to regulate the amount of calcium and
phosphorus in the body. It is best known for its role in using calcium to help build bones and
keep them strong. Vitamin D participates in a feedback loop to maintain calcium levels within
the regulated range (Lin et al, 2007). Vitamin D affects many other tissues of the body, including
the kidneys, intestines, and parathyroid glands. Some experts note that vitamin D acts more like a
hormone than a vitamin, in part because the body can make its own vitamin D if the skin gets
enough ultraviolet (UV) rays from sunlight. Vitamin D is needed to keep a balance between
calcium and phosphorus in the body by controlling how much of these nutrients are absorbed
from foods or taking them from bones when needed. While known for its role in building bones
and keeping them strong, the exact function of vitamin D in other cells and organs is not fully
known (American Cancer Society, 2009).

Vitamin D receptors are found in multiple places throughout body tissues, including
normal breast tissue. The active metabolite of vitamin D (25OH-D) has been shown to downregulate estrogen receptor expression and limit induction of the progesterone receptor. As
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estrogen attaches to the receptors in breast tissue and causes cell proliferation during each
menstrual cycle, the down regulation of this receptor by vitamin D analogs ultimately lowers
breast cell proliferation, a major factor in the development of cancers (Yanuskiewicz, 2010).
Vitamin D and its metabolites reduce the incidence of many types cancer by inhibiting tumor
angiogenesis, which stimulates mutual adherence of cells and enhances intercellular
communication through gap junctions (Garland et al, 2006).

Vitamin D can be ingested through a few natural food sources such as dairy foods and
supplements or can be obtained through UV radiation for conversion of 7-dehydrocholesterol
into vitamin D in the skin. It is then hydroxylated in the liver to produce 25-hydrocholecalciferol.
The circulating 25-hydroxycholecalciferol is then further converted into 1,25-dihydroxyvitamin
D, which is the active form of vitamin D that binds to vitamin D receptors in target tissues such
as the mammary gland (Lin et al, 2007).

Vitamin D deficiency is defined as a low serum level of 25-hydroxyvitamin D, which is
the principal form of circulating vitamin D, and is the main marker of vitamin D deficiency. The
range in which 25-hydroxyvitamin D is considered deficient is less than 15 to 20 ng/mL
(Garland et al, 2006).

Literature Review

A complete list of the effects vitamin D can have on the body is unknown. Evidence for
an association between vitamin D and breast cancer has not been consistent in previous studies,
which show an inverse association only in premenopausal women, in postmenopausal women
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with estrogen-receptor positive tumors, or no association at all (Abbas, Linseisen, &ChangClaude, 2007).
Authors Garland, Garland, Gorham, Lipkin, Newmark, Mohr, & Holick searched
PubMed in December of 2004 for epidemiological studies of vitamin D, sunlight, ultraviolet
radiation, and latitude (2004). The search yielded 63 studies including 30 of colon cancer, 13 of
breast cancer, 26 of prostate cancer, and 7 of ovarian cancer. Twenty of the 30 studies of colon
cancer found a statistically significant benefit of vitamin D, sunlight exposure, its serum
metabolites, or another marker of vitamin D status on cancer risk or mortality and incidence of
adenomatous polyps. Of the 13 studies of breast cancer, 9 studies reported an association of
vitamin D markers or sunlight with cancer risk. Of the 26 studies of prostate cancer, 13 found a
statistically significant association with vitamin D and cancer risk. Five of the seven studies of
ovarian cancer found a higher mortality associated with lower regional sunlight or lower vitamin
D intake (Garland et al, 2006).
Total calcium and vitamin D intake was evaluated in relation to breast cancer incidence
in a study conducted by Lin, Manson, Lee, Cook, Buring, and Zhang. The above was evaluated
among 10,578 premenopausal and 20,909 postmenopausal women who were cancer and
cardiovascular disease free at baseline in the Women’s Health Study. The participants dietary
intake was assessed by the food frequency questionnaire. The authors used Cox proportional
hazards regression to estimate hazard ratios and 95% confidence intervals. Results showed
during an average of 10 years of follow up, 276 of the premenopausal women and 743
postmenopausal women had a confirmed diagnosis of invasive breast cancer. In premenopausal
women, intakes of both calcium and vitamin D were moderately associated with a lower risk of
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breast cancer, however intakes of both nutrients were not inversely associated with the risk of
breast cancer among postmenopausal women (Lin et al, 2007).
Authors Lappe, Travers-Gustafson, Davies, Recker, and Heaney (2007) conducted a 4
year, population based, double-blind, randomized placebo-controlled trial to analyze the efficacy
of calcium alone and calcium plus vitamin D in reducing incident cancer risk of all types. The
subjects consisted of 1,179 community-dwelling women who were randomly selected from a
population of healthy postmenopausal women aged 55yrs and older in a rural area of Nebraska.
The subjects were randomly assigned to receive 1400-1500mg calcium supplementation,
supplemental calcium plus 1100 IU vitamin D3, or placebo. Results of the study showed
improving calcium and vitamin D nutritional status substantially reduces all cancer risk in
postmenopausal women. By evidence of use of logistical regression, results showed the cancer
incidence was lower in the calcium plus vitamin D3 subjects than the placebo subjects (P<0.03),
(Lappe et al, 2007).
Also, authors Robien, Culter, and Lazovich (2007) evaluated the association between
vitamin D intake and breast cancer risk among women in a large prospective cohort study. A
total of 34,321 postmenopausal women who had completed a questionnaire that included diet
and supplement use were followed for breast cancer incidence from 1986 to 2004. Adjusted
relative risks for breast cancer were calculated for dietary, supplemental, and total vitamin D
intake among all women. The adjusted relative risk of breast cancer for women consuming >800
IU/day versus <400 IU/day total vitamin D was 0.89 with 95% confidence interval ranging from
0.77-1.03. Results overall showed that vitamin D intake of >800 IU/day appeared to be
associated with a small decrease in risk of breast cancer among postmenopausal women.
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However, more studies evaluating all sources of vitamin D are still needed to fully understand
the association between vitamin D and breast cancer risk (Robien, Culter, and Lazovich, 2007).
Contrary to the previous studies, authors Chlebowski, Johnson, Kooperberg, Pettinger,
Wactawski-Wende, Rohan, Rossouw, Lane, O’Sullivan, Yasmeen, Hiatt, Shikany, Vitolins,
Khandekar, & Hubbell (2008) evaluate a randomized clinical trial in examining calcium plus
vitamin D supplementation and the risk of breast cancer. Postmenopausal women (N= 36,282)
who were enrolled in a Women’s Health Initiative clinical trial were randomly assigned to
1000mg of calcium with 400 IU of vitamin D daily or placebo for a mean of seven years.
Baseline serum 25-hydroxyvitamin D levels were assessed in a nested case-control study of
1,067 care patients and 1,067 control subjects. Researchers used a Cox proportional hazards
model to estimate the risk of breast cancer association with random assignment to calcium and
vitamin D. Associations between 25-hydroxyvitamin D serum levels and total vitamin D intake,
body mass index, recreational physical activity, and breast cancer risks were evaluated using
logistical regression models. Results showed invasive breast cancer incidence was similar in both
groups (528 participants in supplement group vs 546 participants in the placebo group; hazard
ratio = 0.96; 95% confidence interval = 0.85 to 1.09). Conclusions made showed calcium and
vitamin D supplementation did not reduce invasive breast cancer incidence in postmenopausal
women (Chlebowski et al, 2008).
A population based case control study by Knight, Lesosky, Barnett, Rabound, and Vieth
was conducted to assess the evidence for a relationship between sources of vitamin D and breast
cancer (2007). During the study, women with newly diagnosed invasive breast cancer were
identified from the Ontario Cancer Registry. Women without breast cancer were identified
through randomly selected residential telephone numbers. Telephone interviews were completed
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for 972 cases and 1,135 controls. Odds ratios and 95% confidence intervals for vitamin D related
variables were estimated using unconditional logistic regression with adjustment for potential
confounders. Results showed reduced breast cancer risks were associated with increasing sun
exposure from ages 10 to 19. The authors concluded they found strong evidence to support the
hypothesis that vitamin D could help prevent breast cancer. However, results suggested that
exposure earlier in life may be most relevant and that more studied needed to be conducted to
confirm results (Knight et al, 2007).
The next article reviewed, Dietary Vitamin D and Calcium Intake and Premenopausal
Breast Cancer Risk in a German Case-Control Study was by Abbas, Linseisen, and ChangClaude. The researchers conducted a population based case-control study. Participants were
recruited from two study regions in southern Germany. Two controls per case, latched by exact
age and study region were selected from a random list of residents provided by the population
registries. The cases n= 706, controls n= 1,020. All study participants gave informed consent and
the study was reviewed and approved by the ethics committee of the University of Heidelberg.
Researchers assessed the association of dietary vitamin D and calcium and premenopausal breast
cancer risk by means of logistic regression with stratification according to age. Odds ratio
estimates and their 95% confidence intervals were calculated with SAS statistical software.
Results show breast cancer risk was significantly inversely associated with vitamin D intake but
not calcium intake.
Lastly, authors Mohr, Garland, Gorham, Grant, & Garland investigated the relationship
of modeled and measured serum 25-hydroxyvitamin D levels with age standardized incidence
rates of breast cancer in 107 countries (2008). A multiple regression approach was used to show
the contributions of ultraviolet B irradiance to age standardized incidence rates of breast cancer

9

Running head: VITAMIN D AND PREVENTION OF BREAST CANCER

10

in the 107 countries. Results showed increasing increments in serum 25-hydroxyvitamin D were
associated with incrementally lower incidence rates of breast cancer (Mohr, Garland, Gorham,
Grant, & Garland, 2007).
Counseling and Education
Generally, throughout the United States, the estimated daily solar exposure needed to maintain a
serum 25(OH)D level of 30 ng/mL is 15 minutes in summer and 20 minutes in early fall or late
spring from 11am to 2pm under clear skies with full exposure of arms, shoulders and back
(Garland et al, 2006). Unfortunately, during November to March north of 37 degrees latitude in
the Northeastern and mid Atlantic regions, no amount of sun exposure is sufficient . Therefore,
oral supplementation of vitamin D is needed through food consumption or vitamin supplements.
Based on its review of data of vitamin D needs, a committee of the Institute of Medicine
concluded that persons are at risk of vitamin D deficiency at serum 25(OH)D concentrations <30
nmol/L (<12 ng/mL) (Office of Dietary Supplements, National Institutes of Health, 2011).
There are only a few foods that are good sources of vitamin D. Suggested dietary sources
of vitamin D by AlgaeCal are listed below.

International
Units(IU)
per serving

Percent DV
DailyValue)*

1,360

340

Salmon, cooked, 3½ ounces

360

90

Mackerel, cooked, 3½ ounces

345

90

Tuna fish, canned in oil, 3 ounces

200

50

Sardines, canned in oil, drained, 1¾ ounces

250

70

Food
Pure Cod liver oil, 1 Tablespoon (Note: most refined
cod liver oils today have the vitamin D removed!
Check your label to be certain.)
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Milk, nonfat, reduced fat, and whole, vitamin D
fortified, 1 cup

98

25

Margarine, fortified, 1 Tablespoon

60

15

Pudding, prepared from mix and made with vitamin
D fortified milk, ½ cup

50

10

Ready-to-eat cereals fortified with 10% of the DV
for vitamin D, ¾ cup to 1 cup servings (servings
vary according to the brand)

40

10

Egg, 1 whole (vitamin D is found in egg yolk)

20

6

Liver, beef, cooked, 3½ ounces

15

4

Cheese, Swiss, 1 ounce

12

4

Figure 2: Selected Food Sources of Vitamin D. Source AlgaeCal (available at
http://www.algaecal.com/vitamin-d/vitamin-d-sources.html )

The Food and Nutrition Board established a Recommended Dietary Allowance (RDA)
for vitamin D representing a daily intake that is sufficient to maintain bone health and normal
calcium metabolism in healthy people. Even though sunlight may be a major source of vitamin D
for some, the vitamin D RDAs are set on the basis of minimal sun exposure (Office of Dietary
Supplements, National Institutes of Health, 2011). The current recommendations for vitamin D
supplementation by the National Institute of Health are as follows:

Age

Male
400 IU
(10 mcg)

Female
400 IU
(10 mcg)

1–13 years

600 IU
(15 mcg)

600 IU
(15 mcg)

14–18 years

600 IU
(15 mcg)

19–50 years
51–70 years

0–12 months*

Pregnancy

Lactation

600 IU
(15 mcg)

600 IU
(15 mcg)

600 IU
(15 mcg)

600 IU
(15 mcg)

600 IU
(15 mcg)

600 IU
(15 mcg)

600 IU
(15 mcg)

600 IU

600 IU
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Age

Male

Female

(15 mcg)

(15 mcg)

800 IU
(20 mcg)
* Adequate Intake (AI)

800 IU
(20 mcg)

>70 years

Pregnancy

12

Lactation

Figure 3: Recommended Dietary Allowances (RDAs) for Vitamin D. Source Office of Dietary Supplements,
National Institute of Health. (available at :http://ods.od.nih.gov/factsheets/VitaminD/)

Summary Recommendations
Though the chart above shows the recommended daily dosages, the studies examined in
this paper show a need to increase the daily dosage of vitamin D in order to produce a
chemopreventative effect on breast cancer. It has been suggested that 1000 IU/d of vitamin D
intake is needed to achieve adequate vitamin D concentrations in the body (Lin et al, 2007). In
the study by Robien, Cutler, and Lazovich (2007) it was not until vitamin D intakes reached
>800 IU/day for it to show a small decrease in the risk of breast cancer among postmenopausal
women. Garland et al go as far as to say the lower limit for any benefit of vitamin D would
correspond to 2000 IUs of vitamin D for the first meaningful increment of breast cancer
prevention (2007). It has also been shown that vitamin D dosages of up to 1000 IU per day are
not likely to produce toxicity and the National Academy of Sciences-Institute of Medicine has
indicated that 2000 IU per day is the safe upper limit of vitamin D intake (Garland et al, 2006).
Toxicity of vitamin D generally only occurs when the daily dose exceeds 10,000 IU on a chronic
basis (Garland et al, 2007).
Studies on whether or not vitamin D has a preventative effect against breast cancer have
been inconclusive as the studies in the literature review demonstrate. However, with that being
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said, strong evidence indicates that intake or synthesis of vitamin D in increased amounts is
associated with reduced incidence and death rates of breast cancer along with multiple other
types of cancer. Also, vitamin D status differs by latitude, with residents in the northeastern
United States being at increased risk of deficiency (Garland et al, 2007). More studies examining
the effects of higher doses of vitamin D and its effect against breast cancer are needed before
recommended intakes of vitamin D can be made.
Trusted Resources for Patient Education and Vitamin D Information
1. Office of Dietary Supplements/ National Institute of Health at:
http://ods.od.nih.gov/factsheets/VitaminD
2. The Mayo Clinic at: http://www.mayoclinic.com/health/vitamin-d/NS_patient-vitamind
3. Medline Plus at: http://www.nlm.nih.gov/medlineplus/ency/article/002405.htm
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